Transforming Growth Factor-β Signaling Pathway in Patients With Kawasaki Disease
Authors:
- Chisato ShimizuCSChisato Shimizu
- Sonia JainSJSonia Jain
- Sonia DavilaSDSonia Davila
- Martin L. HibberdMHMartin L. Hibberd
- Kevin O. LinKLKevin O. Lin
- Delaram MolkaraDMDelaram Molkara
- Jeffrey R. FrazerJFJeffrey R. Frazer
- Shelly SunSSShelly Sun
- Annette L. BakerABAnnette L. Baker
- Jane W. NewburgerJNJane W. Newburger
- Anne H. RowleyARAnne H. Rowley
- Stanford T. ShulmanSSStanford T. Shulman
- 1 February 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Genetics
- Vol. 4 (1) , 16-25
Abstract
Background—: Transforming growth factor (TGF)-β is a multifunctional peptide that is important in T-cell activation and cardiovascular remodeling, both of which are important features of Kawasaki disease (KD). We postulated that variation in TGF-β signaling might be important in KD susceptibility and disease outcome. Methods and Results—: We investigated genetic variation in 15 genes belonging to the TGF-β pathway in a total of 771 KD subjects of mainly European descent from the United States, the United Kingdom, Australia, and the Netherlands. We analyzed transcript abundance patterns using microarray and reverse transcriptase–polymerase chain reaction for these same genes, and measured TGF-β2 protein levels in plasma. Genetic variants in TGFB2 , TGFBR2 , and SMAD3 and their haplotypes were consistently and reproducibly associated with KD susceptibility, coronary artery aneurysm formation, aortic root dilatation, and intravenous immunoglobulin treatment response in different cohorts. A SMAD3 haplotype associated with KD susceptibility replicated in 2 independent cohorts and an intronic single nucleotide polymorphism in a separate haplotype block was also strongly associated (A/G, rs4776338) ( P =0.000022; odds ratio, 1.50; 95% confidence interval, 1.25 to 1.81). Pathway analysis using all 15 genes further confirmed the importance of the TGF-β pathway in KD pathogenesis. Whole-blood transcript abundance for these genes and TGF-β2 plasma protein levels changed dynamically over the course of the illness. Conclusions—: These studies suggest that genetic variation in the TGF-β pathway influences KD susceptibility, disease outcome, and response to therapy, and that aortic root and coronary artery Z scores can be used for phenotype/genotype analyses. Analysis of transcript abundance and protein levels further support the importance of this pathway in KD pathogenesis.Keywords
This publication has 42 references indexed in Scilit:
- Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistanceHuman Immunology, 2010
- When Children With Kawasaki Disease Grow UpJACC, 2009
- Association of the TGF-β receptor genes with abdominal aortic aneurysmEuropean Journal of Human Genetics, 2009
- A Genome-Wide Association Study Identifies Novel and Functionally Related Susceptibility Loci for Kawasaki DiseasePLOS Genetics, 2009
- Genetic Variation in an Individual Human ExomePLOS Genetics, 2008
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008
- ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysmsNature Genetics, 2007
- Gene-expression patterns reveal underlying biological processes in Kawasaki diseaseGenome Biology, 2007
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004